rs74349534

Variant summary

Our verdict is Benign. The variant received -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2

The NM_006080.3(SEMA3A):​c.267A>G​(p.Gln89Gln) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0107 in 1,608,202 control chromosomes in the GnomAD database, including 132 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0087 ( 9 hom., cov: 32)
Exomes 𝑓: 0.011 ( 123 hom. )

Consequence

SEMA3A
NM_006080.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 1.78

Publications

6 publications found
Variant links:
Genes affected
SEMA3A (HGNC:10723): (semaphorin 3A) This gene is a member of the semaphorin family and encodes a protein with an Ig-like C2-type (immunoglobulin-like) domain, a PSI domain and a Sema domain. This secreted protein can function as either a chemorepulsive agent, inhibiting axonal outgrowth, or as a chemoattractive agent, stimulating the growth of apical dendrites. In both cases, the protein is vital for normal neuronal pattern development. Increased expression of this protein is associated with schizophrenia and is seen in a variety of human tumor cell lines. Also, aberrant release of this protein is associated with the progression of Alzheimer's disease. [provided by RefSeq, Jul 2008]
SEMA3A Gene-Disease associations (from GenCC):
  • skeletal dysplasia
    Inheritance: AR Classification: DEFINITIVE Submitted by: G2P
  • hypogonadotropic hypogonadism 16 with or without anosmia
    Inheritance: AD Classification: STRONG, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • multiple congenital anomalies/dysmorphic syndrome
    Inheritance: AR Classification: MODERATE Submitted by: Ambry Genetics
  • Brugada syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Kallmann syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -17 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.52).
BP6
Variant 7-84134797-T-C is Benign according to our data. Variant chr7-84134797-T-C is described in ClinVar as Benign. ClinVar VariationId is 1293022.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=1.78 with no splicing effect.
BS2
High Homozygotes in GnomAd4 at 9 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SEMA3ANM_006080.3 linkc.267A>G p.Gln89Gln synonymous_variant Exon 2 of 17 ENST00000265362.9 NP_006071.1 Q14563
SEMA3AXM_005250110.4 linkc.267A>G p.Gln89Gln synonymous_variant Exon 5 of 20 XP_005250167.1 Q14563
SEMA3AXM_047419751.1 linkc.267A>G p.Gln89Gln synonymous_variant Exon 6 of 21 XP_047275707.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SEMA3AENST00000265362.9 linkc.267A>G p.Gln89Gln synonymous_variant Exon 2 of 17 1 NM_006080.3 ENSP00000265362.3 Q14563
SEMA3AENST00000436949.5 linkc.267A>G p.Gln89Gln synonymous_variant Exon 3 of 18 5 ENSP00000415260.1 Q14563
SEMA3AENST00000420047.1 linkc.267A>G p.Gln89Gln synonymous_variant Exon 3 of 5 4 ENSP00000391900.1 C9J9C4

Frequencies

GnomAD3 genomes
AF:
0.00873
AC:
1329
AN:
152236
Hom.:
9
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00212
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00524
Gnomad ASJ
AF:
0.000576
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000827
Gnomad FIN
AF:
0.0267
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0127
Gnomad OTH
AF:
0.00478
GnomAD2 exomes
AF:
0.00974
AC:
2407
AN:
247008
AF XY:
0.00976
show subpopulations
Gnomad AFR exome
AF:
0.00180
Gnomad AMR exome
AF:
0.00447
Gnomad ASJ exome
AF:
0.00101
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0303
Gnomad NFE exome
AF:
0.0130
Gnomad OTH exome
AF:
0.0113
GnomAD4 exome
AF:
0.0109
AC:
15861
AN:
1455848
Hom.:
123
Cov.:
30
AF XY:
0.0105
AC XY:
7579
AN XY:
724368
show subpopulations
African (AFR)
AF:
0.00138
AC:
46
AN:
33216
American (AMR)
AF:
0.00484
AC:
213
AN:
44002
Ashkenazi Jewish (ASJ)
AF:
0.00108
AC:
28
AN:
25952
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39500
South Asian (SAS)
AF:
0.00131
AC:
112
AN:
85516
European-Finnish (FIN)
AF:
0.0297
AC:
1582
AN:
53304
Middle Eastern (MID)
AF:
0.00505
AC:
29
AN:
5738
European-Non Finnish (NFE)
AF:
0.0120
AC:
13338
AN:
1108486
Other (OTH)
AF:
0.00853
AC:
513
AN:
60134
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.477
Heterozygous variant carriers
0
696
1393
2089
2786
3482
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
502
1004
1506
2008
2510
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00872
AC:
1329
AN:
152354
Hom.:
9
Cov.:
32
AF XY:
0.00934
AC XY:
696
AN XY:
74502
show subpopulations
African (AFR)
AF:
0.00212
AC:
88
AN:
41590
American (AMR)
AF:
0.00523
AC:
80
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.000576
AC:
2
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5186
South Asian (SAS)
AF:
0.000828
AC:
4
AN:
4832
European-Finnish (FIN)
AF:
0.0267
AC:
284
AN:
10618
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0127
AC:
861
AN:
68042
Other (OTH)
AF:
0.00473
AC:
10
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
71
142
213
284
355
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0102
Hom.:
6
Bravo
AF:
0.00697
Asia WGS
AF:
0.000866
AC:
3
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:4
Jan 08, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nov 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

SEMA3A: BP4, BP7, BS1, BS2 -

Mar 31, 2020
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

SEMA3A-related disorder Benign:1
Jun 15, 2021
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.52
CADD
Benign
8.9
DANN
Benign
0.57
PhyloP100
1.8
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs74349534; hg19: chr7-83764113; COSMIC: COSV54890634; API